Listed

CVS HEALTH Corp: Form 10-K for the period ended Dec 31, 2015

Filed with the SEC on Feb 9, 2016 and accepted by EDGAR at Feb 9, 2016, 16:29 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-10-01 to 2015-12-31$41.15bnus-gaap:Revenues
Revenue12 months2015-01-01 to 2015-12-31$153.29bnus-gaap:Revenues
Cost of revenue12 months2015-01-01 to 2015-12-31$126.76bnus-gaap:CostOfRevenue
Gross profit3 months2015-10-01 to 2015-12-31$7.30bnus-gaap:GrossProfit
Gross profit12 months2015-01-01 to 2015-12-31$26.53bnus-gaap:GrossProfit
Operating income3 months2015-10-01 to 2015-12-31$2.73bnus-gaap:OperatingIncomeLoss
Operating income12 months2015-01-01 to 2015-12-31$9.45bnus-gaap:OperatingIncomeLoss
Interest expense12 months2015-01-01 to 2015-12-31$859.0mus-gaap:InterestExpense
Income tax12 months2015-01-01 to 2015-12-31$3.39bnus-gaap:IncomeTaxExpenseBenefit
Diluted EPS3 months2015-10-01 to 2015-12-31$1.34us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2015-01-01 to 2015-12-31$4.63us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-10-01 to 2015-12-31$1.35us-gaap:EarningsPerShareBasic
Basic EPS12 months2015-01-01 to 2015-12-31$4.66us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2015-01-01 to 2015-12-311,126,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2015-01-01 to 2015-12-31$8.41bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2015-01-01 to 2015-12-31$2.37bnus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2015-01-01 to 2015-12-31$1.58bnus-gaap:PaymentsOfDividends
Share repurchases12 months2015-01-01 to 2015-12-31$5.00bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2015-12-31$2.46bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-12-31$30.38bnus-gaap:AssetsCurrent
Total assetsAt period end2015-12-31$93.66bnus-gaap:Assets
Current liabilitiesAt period end2015-12-31$23.17bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2015-12-31$26.27bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2015-12-31$1.20bnus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2015-12-31$0us-gaap:ShortTermBorrowings
Shareholders' equityAt period end2015-12-31$37.20bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000064803-16-000074. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.